die('
Site is under construction
Dear site users
Site is under construction.
The site will be ready in less than 24 hours.
We are sorry for the inconvenience.
www.yektaweb.com
');
Reports of Biochemistry and Molecular Biology
rbmb.net
Basic Sciences
http://rbmb.net
1
admin
2322-3480
2322-3480
10.61882/rbmb
en
jalali
1398
10
1
gregorian
2020
1
1
8
4
online
1
fulltext
en
The Gene Expression Profile and DNA Methylation Pattern of CDH1 and DNMT1 Genes in Acute Promyelocytic Leukemia (APL)
زیست شناسی ملکولی
Molecular Biology
مقالات اصلی
Original Article
<div style="text-align: justify;"><strong><em>Background:</em></strong> DNA methylation is an epigenetic modification that has the ability to alter gene expression and function. These epigenetic changes have been associated with the development of cancer. Previous research has found that DNA methylation patterns can predict disease prognosis for patients with Acute Promyelocytic Leukemia (APL). The role of DNMT1 and CDH1 in regulating the extension of cells are studied in this study.<br>
<br>
<strong><em>Methods:</em></strong> DNA was extracted from peripheral blood samples of APL patients and treated with bisulfite. DNMT1 and CDH1 gene promoter methylation was subsequently analyzed using methylation-specific PCR (MSP). Real-time PCR was used to measure the expression level of DNMT1 and CDH1 genes.<br>
<br>
<strong><em>Results</em></strong><strong><em>:</em></strong> Partial methylation of the CDH1 gene promoter was detected in 20% of APL patients and an unmethylated status was detected in 80% of patient samples. Additionally, an unmethylated status in the DNMT1 gene promoter was detected in 100% of APL patient samples.<br>
<br>
<strong><em>Conclusions:</em></strong> Our study found the CDH1 gene promoter to be unmethylated in almost all APL patients, while the DNMT1 promoter was unmethylated in all APL patients. Furthermore, we observed an increase in both CDH1 and DNMT1 gene expression in APL patients compared to healthy controls. These findings suggest that DNMT1 may not have a specific role in inhibiting CDH1 gene expression in APL. Applying higher resolution techniques would help to better uncover the DNA methylation patterns in patients with APL. Further research is required to determine the role of DNA methylation and CDH1 and DNMT1 gene expression in APL.</div>
Acute Promyelocytic Leukemia, CDH1, DNMT, Promoter Methylation.
454
457
http://rbmb.net/browse.php?a_code=A-10-152-2&slc_lang=en&sid=1
Sanaz
Zebardast
Zebardastsanaz1992@gmail.com
100319475328460017457
100319475328460017457
No
Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Mehdi
Sahmani
M.Sahmani@gmail.com
100319475328460017458
100319475328460017458
No
Department of Biochemistry, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Saeed
Mohammadi
Smohammadi@sina.tums.ac.ir
100319475328460017459
100319475328460017459
No
Hematology-Oncology and stem cell transplantation research center, Tehran university of medical sciences, Tehran, Iran.
Farshad
Foroughi
farshad295@yahoo.com
100319475328460017460
100319475328460017460
No
Department of Immunology, Faculty of Allied Medicine, Qazvin university of Medical Sciences, Qazvin, Iran.
Ali
Dehghani Fard
Ali_dehghani_fard@yahoo.com
100319475328460017461
100319475328460017461
No
Gholhak laboratory of Tehran, Iran.
Zahra
Mohammadi
Heeva-MH.1988@yahoo.com
100319475328460017462
100319475328460017462
No
Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Sahar
Khojastepour
Saharkhojaste62@gmail.com
100319475328460017463
100319475328460017463
No
Cellular and Molecular Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Mehdi
Azad
m.azad@qums.ac.ir
100319475328460017464
100319475328460017464
Yes
Department of Medical laboratory sciences, Faculty of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.